Hepatic Oncology

Hepatic Oncology
影响因子:
1.2
ISSN:
print: 2045-0923
on-line: 2045-0931
研究领域:
ONCOLOGY-
自引率:
0.00%
Gold OA文章占比:
93.33%
原创研究文献占比:
100.00%
SCI收录类型:
Emerging Sources Citation Index (ESCI) || Directory of Open Access Journals (DOAJ)
期刊介绍英文:
Primary liver cancer is the sixth most common cancer in the world, and the third most common cause of death from malignant disease. Traditionally more common in developing countries, hepatocellular carcinoma is becoming increasingly prevalent in the Western world, primarily due to an increase in hepatitis C virus infection. Emerging risk factors, such as non-alcoholic fatty liver disease and obesity are also of concern for the future. In addition, metastatic tumors of the liver are more common than primary disease. Some studies report hepatic metastases in as many as 40 to 50% of adult patients with extrahepatic primary tumors. Hepatic Oncology publishes original research studies and reviews addressing preventive, diagnostic and therapeutic approaches to all types of cancer of the liver, in both the adult and pediatric populations. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy. Hepatic Oncology provides a forum to report and debate all aspects of cancer of the liver and bile ducts. The journal publishes original research studies, full reviews and commentaries, with all articles subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal''s Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
0.40.1550.100
学科
排名
百分位
大类:Medicine
小类:Hepatology
71 / 82
14%
大类:Medicine
小类:Oncology
350 / 404
13%
发文信息
WOS期刊分区
学科分类
Q4ONCOLOGY
历年影响因子
2022年5.0000
2023年1.2000
历年发表
2014年48
2015年47
2016年28
2017年17
2018年10
2019年4
2020年18
2021年10
2022年4
投稿信息
出版语言:
English
出版国家(地区):
United Kingdom
审稿时长:
13 weeks
出版商:
Future Medicine Ltd

Hepatic Oncology - 最新文献

Treatment journey of patients with hepatocellular carcinoma using real-world data in British Columbia, Canada.

Pub Date : 2024-03-14 DOI: 10.2217/hep-2023-0004 Soo Jin Seung, Hasnain Saherawala, Brandon Zagorski, Carman Tong, Howard Lim, Peter Kim, Vladimir Marquez, Sharlene Gill, David Liu, Janine M Davies

The predictive value of liver tests for the presence of liver metastases.

Pub Date : 2023-10-12 DOI: 10.2217/hep-2023-0003 Alexandra V Kimchy, Harjit Singh, Esha Parikh, Jessica Rosenberg, Kavya Sanghavi, James H Lewis

Hepatic arterial infusion chemotherapy with or without lenvatinib for unresectable cholangiocarcinoma: a single-center retrospective study.

Pub Date : 2023-09-29 DOI: 10.2217/hep-2023-0006 Yajing Wang, Zhanqi Wei, Zheng Zhang, Jingyi Xu, Yaqin Wang, Qian Chen, Yuewei Zhang
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信